Past Presentations

IP Watchdog Webinar
May 18th, 2021
12:00PM ET

Crystalline/Solid Form Patents in the Life Sciences: Issues in Prosecution and Litigation

In December of 2020, IPWatchdog hosted a webinar discussing the use of and interest in solid-form patents in the pharmaceutical industry. There were many questions during the webinar, and many follow-up inquiries on the “nuts and bolts” of these patents. Issues including prosecution, claim drafting, novelty, obviousness, enablement, non-species claims in a crystalline-form context, claim interpretation and proving infringement.

Join us on Tuesday, May 18, 2021 at 12 PM, for this follow-on webinar that will dive deeper into these questions from a US-based perspective, and which will also compare and contrast these issues with elements of EU law. Panelists will discuss both court decisions as well as opinions from the USPTO (PTAB) and the EPO.

Pharmalytical Summit 2021
May 26th, 2021
11:00AM ET

Using Solid Form IP to Protect Crucial Pharmaceutical Assets
When medicinal chemists create a new chemical entity, the solid form is rarely optimized because the initial focus is on activity and not drug delivery. As the NCE program matures, however, manufacturing, supply, and drug delivery become increasingly important. These other aspects of drug development present opportunities for patenting and creating value. These and other factors are often dependent on the solid-state structure of the entity. This webinar will discuss some of those opportunities and how resulting IP can be used to protect and leverage the final drug product estate.

July 15th, 2021
Time TBD

Registration Info Coming Soon
More info coming soon